Antidepressant drugs: imipramine, mianserin and trazodone.
The advent of newer antidepressant drugs (second generation) during the past two decades has provided an alternative to the use of tricyclic antidepressants in the alleviation of depression. These antidepressants have not been proven to be superior in the therapy of depression to the tricyclic antidepressants but they have been reported to cause fewer cardiac effects. Most of the reported adverse cardiac reactions elicited by antidepressant drugs are based on observations from clinical studies. The possible underlying mechanisms by which these adverse reactions arise have for the large part been proposed on the basis of clinical findings which have been extrapolated back to the known pharmacological actions of such drugs. There is a paucity of hard experimental data in this respect.
D000818:Animals; D000928:Antidepressive Agents / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D001711:Biotransformation; D006801:Humans; D007099:Imipramine; D008803:Mianserin; D011955:Receptors, Drug; D014196:Trazodone
D000928:Antidepressive Agents; D011955:Receptors, Drug; D008803:Mianserin; D007099:Imipramine; D014196:Trazodone